Page last updated: 2024-10-23

bromhexine and Cancer of the Thymus

bromhexine has been researched along with Cancer of the Thymus in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, F1
Tsuta, K1
Nagaoka, T1
Miyamoto, H1
Saito, Y1
Amano, H1
Uchida, K1
Morio, Y1
Shimizu, K1
Sasaki, S1
Tominaga, S1
Uekusa, T1
Izumi, H1
Anami, Y1
Matsuno, Y1
Takahashi, K1
Fukuchi, Y1

Other Studies

1 other study available for bromhexine and Cancer of the Thymus

ArticleYear
Successful resection of dermatomyositis associated with thymic carcinoma: report of a case.
    Surgery today, 2008, Volume: 38, Issue:3

    Topics: Bromhexine; Dermatomyositis; Humans; Male; Middle Aged; Paraneoplastic Syndromes; Radiography; Thymu

2008